Delivery Order SPE2DB24D2212-SPE2DB24FHNDT
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,543.79 firm fixed-price delivery order is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $1,087.34 Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA). The contract covers the provision of MYDAYIS ER 25 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through October 28, 2024. This award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is for the delivery of MYDAYIS ER 12.5 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, on July 23, 2024 with a ceiling value of $1,659.92 and an ultimate completion date of July 24, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not set-aside. Amerisourcebergen holds a...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $4,068.37 for the pharmaceutical product MYDAYIS ER 12.5 MG CAPSULE 100S. The prime contractor for this award is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 14, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. Amerisourcebergen Drug...
This federal contract award, valued at $1,598.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of October 30, 2024. The contract covers the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen holds a significant...
This federal contract award was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp's Corporate Office division. The $1,261.09 firm fixed price delivery order is for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product, with a period of performance ending on July 10, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp, a subsidiary of the large pharmaceutical distribution company Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,753.40 firm fixed-price delivery order is for the provision of MYDAYIS ER 25 MG CAPSULE 100S, a prescription medication. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical that serves as a...
This federal contract award, valued at $2,308.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Firm Fixed Price Delivery Order for the supply of MYDAYIS ER 50 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,753.09 Firm Fixed Price Delivery Order contract is for the supply of MYDAYIS ER 37.5 MG CAPSULE 100S, a pharmaceutical product. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,975.53, is a delivery order for the supply of 100 units of the drug MYDAYIS ER 50 MG CAPSULE. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...